Cytochrome P450 2B6 Inhibitors [MoA] - N0000182139

Name: Table of NDC products with cytochrome p450 2b6 inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000182139
Pharmacologic Name	Cytochrome P450 2B6 Inhibitors
Pharmacologic Uses	anthelmintic cortisol synthesis inhibitor kinase inhibitor nitroimidazole antimicrobial selective norepeinephrine reuptake inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Cytochrome P450 2B6 Inhibitors

The table contains 19 products whose active ingredient are classified under the same pharmacologic class Cytochrome P450 2B6 Inhibitors [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0024-4512	Fexinidazole	Non-Proprietary Name: Fexinidazole	Tablet	Oral	Sanofi-aventis U.s. Llc	ACTIVE
0069-0251	Xalkori	Non-Proprietary Name: Crizotinib	Capsule, Coated Pellets	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-0507	Xalkori	Non-Proprietary Name: Crizotinib	Capsule, Coated Pellets	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-1500	Xalkori	Non-Proprietary Name: Crizotinib	Capsule, Coated Pellets	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-8140	Xalkori	Non-Proprietary Name: Crizotinib	Capsule	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0069-8141	Xalkori	Non-Proprietary Name: Crizotinib	Capsule	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
0078-0937	Egaten	Non-Proprietary Name: Triclabendazole	Tablet	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
10191-6374	Cannabis Sativa	Non-Proprietary Name: Cannabis Sativa	Liquid	Oral	Remedy Makers	ACTIVE
17772-131	Qelbree	Non-Proprietary Name: Viloxazine Hydrochloride	Capsule, Extended Release	Oral	Supernus Pharmaceuticals, Inc	ACTIVE
17772-132	Qelbree	Non-Proprietary Name: Viloxazine Hydrochloride	Capsule, Extended Release	Oral	Supernus Pharmaceuticals, Inc	ACTIVE
17772-133	Qelbree	Non-Proprietary Name: Viloxazine Hydrochloride	Capsule, Extended Release	Oral	Supernus Pharmaceuticals, Inc	ACTIVE
65597-407	Turalio	Non-Proprietary Name: Pexidartinib Hydrochloride	Capsule	Oral	Daiichi Sankyo, Inc.	ACTIVE
70127-100	Epidiolex	Non-Proprietary Name: Cannabidiol	Solution	Oral	Jazz Pharmaceuticals, Inc.	ACTIVE
71699-025	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
71699-050	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
71699-100	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
71699-150	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
71699-200	Xcopri	Non-Proprietary Name: Cenobamate	Tablet, Film Coated	Oral	Sk Life Science, Inc.	ACTIVE
72065-003	Recorlev	Non-Proprietary Name: Levoketoconazole	Tablet	Oral	Xeris Pharmaceuticals, Inc.	ACTIVE